How Did U.S. Assess Iraqi Bioweapon Production?
One of the most vivid allegations made by the U.S. government regarding Iraqi weapons of mass destruction was the claim that Iraqi had developed mobile laboratories for the production of biological weapons. The allegation, based on reports from a source known as “Curveball,” proved to be false.
But the U.S. intelligence assessment of the supposed mobile BW labs, though erroneous, raised questions that still remain unanswered, wrote (pdf) bioweapons expert Milton Leitenberg of the University of Maryland.
According to a cryptic reference spotted by Leitenberg in the Silberman-Robb WMD Commission report, U.S. contractors performed a “replication” of the Iraqi design and found that “it works.”
The exact nature of this “replication” and whether it led to the production of actual BW agents are among several lingering questions he posed.
See “Unresolved Questions Regarding US Government Attribution of a Mobile Biological Production Capacity by Iraq” by Milton Leitenberg, June 2006.
Without the permitting workforce needed for implementation, the American public will not reap the benefits of rural broadband access, resilient supply chains, and clean, accessible water.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote